As far as the PI3K pathway is concerned, mutations of the well-known oncogene, PIK3CA, occur far more frequently in HPV(+) HNSCC than in EBV(+) NPC (Table 3; 36% cases vs. 4% cases, respectively). The gene discussed is PIK3CA; the disease is nasopharyngeal carcinoma.